• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Milestone Scientific wins Health Canada license for epidural drug-delivery system

March 27, 2018 By Sarah Faulkner

Milestone ScientificHealth Canada issued a medical device license to Milestone Scientific (NYSE:MLSS) this week for the company’s CompuFlo Epidural computer-controlled anesthesia system.

The Livingston, N.J.-based company developed CompuFlo Epidural to use dynamic pressure sensing to help anesthesiologists correctly identify the epidural space and reduce complications in real-time.

The system also has 510(k) clearance in the U.S.

“Receiving a medical device license in Canada is another important step in our global roll-out strategy. Over the past year, we have been primarily focused on building relationships with key opinion leaders around the world,” interim CEO Leonard Osser said in prepared remarks.

“At the same time, we are lining up distributors in major markets throughout North America and Europe. Importantly, we expect to see the results of our trials published in leading industry journals later this year, which should help further accelerate our commercial rollout,” he added.

In November last year, Milestone Scientific revealed its plans to launch a cosmetic injection instrument designed to deliver botulinum toxin.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Drug-Device Combinations, Featured, Pain Management, Pharmaceuticals, Regulatory/Compliance, Wall Street Beat Tagged With: milestonescientific

IN CASE YOU MISSED IT

  • Tandem Diabetes Care delivers 1 million insulin boluses using t:connect mobile app
  • Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
  • Verily’s Onduo, Sword Health collaborate on virtual diabetes care
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS